Financial Performance - Revenue for the reporting period was RMB 1,836,117,836.40, a decrease of 10.00% compared to the same period last year[12] - Net profit attributable to shareholders of the listed company was RMB -100,781,590.33, an improvement of 32.87% compared to the same period last year[12] - Net cash flow from operating activities was RMB -408,059,362.80, a significant decrease of 1,074.27% compared to the same period last year[12] - Total assets at the end of the reporting period were RMB 5,522,053,297.20, a slight increase of 0.11% compared to the end of the previous year[12] - The company's non-recurring gains and losses amounted to RMB 9,316,068.26, including government subsidies of RMB 6,441,324.91[14][15] - The company's revenue for the first half of 2024 was 1.84 billion yuan, a year-on-year decrease of 10%, with a net loss attributable to shareholders of 100.78 million yuan[30] - The company's performance loss was primarily due to insufficient market demand for its main products, overcapacity, and intensified industry competition, leading to a significant decline in gross profit[30] - Revenue for the reporting period was 1.84 billion yuan, a decrease of 10.00% year-on-year, primarily due to a decline in product sales[34] - Net cash flow from operating activities was -408.06 million yuan, a significant decrease of 1,074.27% year-on-year, mainly due to increased cash payments for goods[34] - Management expenses increased by 33.99% year-on-year to 83.59 million yuan, primarily due to increased shutdown losses and repair costs[34] - Net cash flow from financing activities increased by 1,699.78% to 254,717,700.42 yuan, mainly due to increased borrowing during the reporting period[35] - Net cash and cash equivalents decreased by 120.79% to -65,586,364.24 yuan, primarily due to higher net cash outflows from operating activities compared to cash inflows from investing and financing activities[35] - Revenue from polyether monomers decreased by 20.32% to 1,200,629,333.34 yuan, with a corresponding decrease in cost of 21.12%[35] - Revenue from polyethylene glycol increased by 26.21% to 231,013,097.78 yuan, with a cost increase of 25.96%[35] - Fixed assets increased by 4.17% to 1,809,106,458.23 yuan, mainly due to the pre-transfer of the Hainan Aoke 200,000 tons/year epoxy-derived green energy new materials project[39] - Short-term borrowings increased by 6.44% to 1,557,982,990.99 yuan, primarily used to supplement working capital[39] - Accounts receivable increased by 2.02% to 457,267,192.19 yuan, mainly due to adjustments in customer repayment policies[39] - Inventory increased by 3.14% to 436,390,337.57 yuan, primarily due to an increase in stock goods at the end of the reporting period[39] - The company's cash and cash equivalents decreased to RMB 408.85 million from RMB 427.55 million at the beginning of the period[157] - Accounts receivable increased to RMB 457.27 million from RMB 345.28 million, reflecting a growth of 32.4%[157] - Inventory rose significantly to RMB 436.39 million from RMB 262.71 million, an increase of 66.1%[157] - Total current assets slightly increased to RMB 1.95 billion from RMB 1.90 billion[157] - Fixed assets grew to RMB 1.81 billion from RMB 1.58 billion, indicating a 14.7% increase[158] - Short-term borrowings increased to RMB 1.56 billion from RMB 1.20 billion, a 29.7% rise[158] - Total liabilities increased to RMB 2.46 billion from RMB 2.34 billion[159] - Retained earnings decreased to RMB 225.08 million from RMB 325.86 million, a drop of 30.9%[159] - Total equity decreased to RMB 3.07 billion from RMB 3.18 billion[159] - The company's total assets remained relatively stable at RMB 5.52 billion compared to RMB 5.52 billion at the beginning of the period[159] - Total operating revenue for the first half of 2024 was 1,836,117,836.40 RMB, a decrease from 2,040,052,741.10 RMB in the same period of 2023[163] - Total operating costs for the first half of 2024 were 1,958,076,533.61 RMB, compared to 2,197,133,098.00 RMB in the first half of 2023[164] - The company reported a net loss of 115,170,596.29 RMB for the first half of 2024, compared to a net loss of 147,100,682.80 RMB in the same period of 2023[164] - Total assets as of the end of the first half of 2024 were 4,146,825,935.51 RMB, an increase from 3,924,316,094.02 RMB at the end of the first half of 2023[161] - Total liabilities as of the end of the first half of 2024 were 1,277,446,638.75 RMB, up from 1,081,507,840.66 RMB at the end of the first half of 2023[162] - The company's total equity as of the end of the first half of 2024 was 2,869,379,296.76 RMB, compared to 2,842,808,253.36 RMB at the end of the first half of 2023[162] - Research and development expenses for the first half of 2024 were 21,196,006.20 RMB, a decrease from 25,753,234.24 RMB in the same period of 2023[164] - The company's accounts receivable as of the end of the first half of 2024 were 28,420,654.90 RMB, down from 36,672,838.40 RMB at the end of the first half of 2023[161] - Total current assets as of the end of the first half of 2024 were 939,372,952.08 RMB, an increase from 712,413,250.29 RMB at the end of the first half of 2023[161] - The company's inventory as of the end of the first half of 2024 was 17,111,143.43 RMB, down from 24,545,277.46 RMB at the end of the first half of 2023[161] - Revenue for the first half of 2024 was RMB 243.72 million, a decrease of 1.97% compared to RMB 248.63 million in the same period of 2023[167] - Net profit attributable to the parent company's shareholders was a loss of RMB 100.78 million, compared to a loss of RMB 150.12 million in the first half of 2023, showing a reduction in losses[165] - Operating cash flow for the first half of 2024 was negative RMB 408.06 million, a significant decline from the positive RMB 41.88 million in the same period of 2023[169] - Sales of goods and services generated cash inflows of RMB 1.97 billion in the first half of 2024, an increase of 4.46% compared to RMB 1.88 billion in the same period of 2023[169] - The company's R&D expenses decreased by 21.30% to RMB 3.33 million in the first half of 2024, down from RMB 4.24 million in the same period of 2023[167] - Basic earnings per share (EPS) for the first half of 2024 was a loss of RMB 0.15, an improvement from the loss of RMB 0.22 in the same period of 2023[165] - Total comprehensive income for the first half of 2024 was a loss of RMB 99.63 million, compared to a loss of RMB 144.18 million in the same period of 2023[165] - The company's income tax expense for the first half of 2024 was RMB 167,003, compared to a tax benefit of RMB 822,231 in the same period of 2023[167] - Cash received from tax refunds increased by 54.89% to RMB 49.06 million in the first half of 2024, up from RMB 31.67 million in the same period of 2023[169] - The company's financial expenses increased by 13.46% to RMB 8.55 million in the first half of 2024, compared to RMB 7.54 million in the same period of 2023[167] - Investment activities generated a net cash flow of RMB 83.97 million, compared to RMB 285.91 million in the previous period[171] - Financing activities resulted in a net cash inflow of RMB 254.72 million, a significant improvement from a net outflow of RMB 15.92 million in the prior period[171] - The company's cash and cash equivalents decreased by RMB 65.59 million, ending the period with RMB 350.81 million[171] - Operating activities generated a net cash flow of RMB 275.59 million, a substantial recovery from a net outflow of RMB 113.00 million in the previous period[172] - Investment activities resulted in a net cash outflow of RMB 267.86 million, compared to a net inflow of RMB 40.61 million in the prior period[173] - Financing activities generated a net cash inflow of RMB 118.74 million, a significant improvement from a net outflow of RMB 2.33 million in the previous period[173] - The company's cash and cash equivalents increased by RMB 5.40 million, ending the period with RMB 57.51 million[173] - Total owner's equity at the end of the period was RMB 3.18 billion, with minority interests amounting to RMB 236.51 million[174] - The company's initial balance for the period was RMB 680,098,200.00, with total assets of RMB 3,176,061,360.63[175] - The company's comprehensive income for the period decreased by RMB 100,781,590.33, resulting in a total comprehensive income of RMB -101,013,623.95[175] - The company's profit distribution to shareholders amounted to RMB -11,416,860.31[175] - The company's special reserve decreased by RMB 481,698.20, with a total usage of RMB 15,484,012.69[176] - The company's ending balance for the period was RMB 680,098,200.00, with total assets of RMB 3,065,460,269.67[176] - The company's capital reserve increased by RMB 721,945.55 during the period[178] - The company's comprehensive income for the period decreased by RMB 150,119,945.46, resulting in a total comprehensive income of RMB -150,068,829.29[178] - The company's profit distribution to shareholders amounted to RMB -18,788,585.93[178] - The company's total comprehensive income for the first half of 2024 was RMB 25,708,498.33[181] - The company's capital reserve increased by RMB 810,508.58 during the first half of 2024[182] - The company's special reserve increased by RMB 52,036.49 in the first half of 2024[182] - The company's undistributed profit increased by RMB 25,708,498.33 in the first half of 2024[181] - The company's total owner's equity at the end of the first half of 2024 was RMB 2,869,379,296.76[182] - The company's capital reserve at the end of the first half of 2024 was RMB 1,743,874,880.26[182] - The company's special reserve at the end of the first half of 2024 was RMB 3,264,404.54[182] - The company's undistributed profit at the end of the first half of 2024 was RMB 240,430,416.86[182] - The company's total owner's equity at the beginning of 2024 was RMB 2,842,808,253.36[181] - The company's capital reserve at the beginning of 2024 was RMB 1,743,064,371.68[181] - The company's total assets as of the end of the reporting period amounted to RMB 2,878,278,683.85[185] - The company's operating income for the current period was RMB 2,359,966.73[185] - The company's net profit for the current period was RMB 721,945.55[185] - The company's registered capital as of June 30, 2024, was RMB 680,098,200.00[186] - The company's total liabilities as of the end of the reporting period amounted to RMB 1,740,740,088.71[185] - The company's total equity as of the end of the reporting period amounted to RMB 252,464,444.13[185] - The company's cash and cash equivalents as of the end of the reporting period amounted to RMB 201,711,395.10[185] - The company's total revenue for the current period was RMB 3,264,555.91[185] - The company's total expenses for the current period were RMB 2,359,966.73[185] - The company's total comprehensive income for the current period was RMB 721,945.55[185] Business Operations and Projects - The company's new lithium battery additive material project, with a capacity of 20,000 tons of ethylene sulfite (ES), was completed and put into production in January 2024[16] - The company's traditional epoxy derivative products, including polyether monomers for water reducers, are widely used in large-scale infrastructure projects both domestically and internationally[16] - The company's new energy materials sector includes products such as ethylene carbonate (EC) and dimethyl carbonate (DMC), which are primarily used in lithium battery electrolytes[16] - From January to June 2024, national fixed asset investment (excluding rural households) was RMB 245,391 billion, an increase of 3.9% year-on-year, with infrastructure investment (excluding electricity, heat, gas, and water production and supply) increasing by 5.4%[16] - The company's lithium-ion battery electrolyte solvent production uses ethylene carbonate, a green fine chemical raw material, with demand closely tied to lithium battery demand, showing a gradual slowdown in growth[18] - In H1 2024, China's new energy vehicle production and sales reached 4.929 million and 4.944 million units respectively, with year-on-year growth rates of 30.1% and 32%, maintaining a market share of 35.2%[18] - China's electrolyte market shipments in 2023 were 1.11 million tons, a year-on-year increase of 31.5%, with June 2024 production reaching 109,810 tons, up 11.9% year-on-year[19] - The global lithium battery market is expected to reach nearly 2,400GWh by 2025, with power batteries accounting for over 1,700GWh, driving more than 70% of the market growth[18] - The domestic pharmaceutical excipients market is expected to grow steadily due to aging population, medical insurance expansion, and increasing demand for pharmaceutical products[20] - China's pharmaceutical excipients market is characterized by intense competition in low-end products and reliance on imports for high-end products, with policies supporting domestic high-quality development[20] - The non-ionic surfactant industry is expected to maintain stable demand growth, driven by the personal care and detergent sectors, with a focus on green and sustainable development[21] - The global construction chemicals market is expected to benefit from infrastructure development in developing countries and emerging economies, particularly in ASEAN regions[17] - The domestic water-reducing agent polyether monomer market faces short-term profit pressure due to insufficient demand and overcapacity, but long-term prospects remain positive[17] - The company's pharmaceutical excipients, primarily high-purity polyethylene glycol, are used in various downstream products including pills, suppositories, and soft capsules[20] - The company's market share of polyether monomer for water-reducing agents remains at the top of the domestic industry, but the market faces overcapacity and weak demand, leading to low prices[22] - The company's carbonate series products achieved a total sales volume of 12,500 tons in the first half of 2024, a year-on-year decrease of 37%, due to increased market competition and reduced profitability[23] - The company's new 20,000-ton ethylene sulfite (ES) project for lithium battery additives was completed and put into production in January 2024, marking the first international use of a new industrial production process[23] - The company's pharmaceutical polyethylene glycol excipients are supplied to over 400 domestic pharmaceutical companies, with plans to expand into overseas markets[24] - The company's non-ionic surfactants, such as OXOE and FMEE, are environmentally friendly and align with national green development policies, offering new growth opportunities[25] - The company has implemented measures such as customer-centric marketing management and elevating subsidiaries to operating entities to achieve loss reduction and efficiency improvement[30] - Export sales reached 35,400 tons, a year-on-year increase of 28.57%[31] - The company obtained 17 authorized patents in the first half of 2024, including 10 invention patents and 7 utility model patents, bringing the total number of valid patents to 330[32] - R&D investment for the reporting period was 62.52 million yuan, a decrease of 14.75% year-on-year[34] - The company's production capacity includes 300,000 tons of commodity ethylene oxide and 1.6 million tons of ethoxylation standard capacity[31] - The company's sales service network covers 80% of customers within a 500-kilometer radius of its production bases[31] - The company has established strategic partnerships with major suppliers such as Sinopec and PetroChina for secure ethylene oxide pipeline delivery[31] - The company's production bases are located in key regions including Liaoning, Jilin, Jiangsu, Hubei, Sichuan, Guangdong,

证券代码：300082 证券简称：奥克股份 公告编号：2024-038 辽宁奥克化学股份有限公司 辽宁奥克化学股份有限公司 关于终止天津聚醚新材料有限公司（筹） 投资新设项目合作的公告 辽宁奥克化学股份有限公司（以下简称"公司"）于2024年8月3日召开第 六届董事会第十一次会议，审议通过了《关于终止天津聚醚新材料有限公司（筹） 投资新设项目合作的议案》。同意终止公司与中国石化集团资产经营管理有限公 司（以下简称"中石化资产公司"）关于天津聚醚新材料有限公司（筹）投资新 设项目（以下简称"合作项目"）的合作。同时，授权公司管理层及相关人士具 体办理合作解除等相关具体事宜。现将有关情况公告如下： 一、原合作项目概况 2022 年 4 月 13 日，公司召开第五届董事会第二十次会议，审议通过《关于 拟以公开摘牌方式参与天津聚醚新材料有限公司（筹）投资新设项目的议案》。 同意公司依据北京产权交易所公示的中国石化集团资产经营管理有限公司天津 石化分公司聚醚部（以下简称"天津石化聚醚部"）经审计的最新一期财务数据 等信息，以适宜的价格参与天津聚醚新材料有限公司（筹）投资新设项目。具体 内容请见公司于 2022 年 4 ...

《公司2024年半年度报告》全文及《公司2024年半年度报告摘要》内容真实、 准确、完整，不存在任何虚假记载、误导性陈述或者重大遗漏，已于同日在巨潮 资讯网（http//www.cninfo.com.cn）披露，并在《中国证券报》、《证券时报》 上刊登《2024年半年度报告披露提示性公告》。 本议案已经公司风控审计委员会审议并取得了明确同意的意见。 辽宁奥克化学股份有限公司 第六届董事会第十一次会议决议公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-041 辽宁奥克化学股份有限公司 第六届董事会第十一次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁奥克化学股份有限公司（以下简称"公司"）第六届董事会第十一次会 议通知于2024年7月24日以通讯、电子邮件发出，会议于2024年8月3日以视频通 讯表决的方式召开。本次会议应参加表决董事9名，实际参加表决董事9名。公司 监事、高级管理人员列席会议，会议由公司董事长朱建民先生主持。会议的召集、 召开和表决程序符合法律、法规及《公司章程》的规定。本次会议经表决，审议 通过以下议案： ...

上市公司 2024 年度 1-6 月 非经营性资金占用及其他关联资金往来情况汇总表 编制单位：辽宁奥克化学股份有限公司 金额单位：人民币万元 | | 上海悉浦奥进出口有限 | 全资子 | 其他应收款 | | 10,000.35 | 42.00 | 42.35 | 10,000.00 | 资金 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 公司 | 公司 | | | | | | | 往来 | | | | 武汉奥克化学有限公司 | 全资子 公司 | 其他应收款 | 4,000.00 | 3,401.04 | 86.45 | 59.19 | 7,428.30 | 资金 往来 | | | | OXIRAN （SINGAPORE） | 全资子 | 其他应收款 | 708.27 | 4.41 | | | 712.68 | 资金 | | | | TRADINGPTE.LTD. | 公司 | | | | | | | 往来 | | | | 上海奥克化学有限公司 | 全资子 公司 | 其他应收款 | | 50.00 | 0. ...

辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示：辽宁奥克化学股份有限公司（以下简称"公司"）控股股东 奥克控股集团股份公司（以下简称"奥克集团"）持有公司股份359,698,573股， 占公司总股本的52.89%。本次股份质押3,824,092股后，奥克集团累计质押数量为 51,444,092股，占其持股数量的14.30%，占公司总股本的7.56%。 辽宁奥克化学股份有限公司 关于控股股东部分股份质押的公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-037 | | | | | | | | 已质押股份情 | | 未质押股份情 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 本次质押前 | | 占其 | 占公 | 况 | | 况 | | | | | | | 本次质押后 | | | 已质押 | | 未质押 | | | 股东名 | 持股数量 | 持股比 | 质押股份数 | ...

辽宁奥克化学股份有限公司 辽宁奥克化学股份有限公司 第六届监事会第八次会议决议公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-036 经核查，监事会认为：公司董事会审议通过的关于变更会计估计事项，其审 议程序符合《公司章程》和有关法律法规的规定。本次会计估计变更，能更真实 地反映公司财务状况和经营成果，符合公司实际情况。同意公司本次会计估计变 更。 表决结果：同意5票，反对0票，弃权0票。 二、备查文件 1、经与会监事签字并加盖监事会印章的《第六届监事会第八次会议决议》 特此公告。 第六届监事会第八次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁奥克化学股份有限公司（以下简称"公司"）第六届监事会第八次会议 通知于2024年6月22日以邮件、电话等通知方式发出，会议于2024年6月26日以通 讯表决的方式召开，本次会议应参加表决监事5人，实际参加表决监事5人。会议 的召集、召开和表决程序符合法律、法规及《公司章程》的规定。本次会议审议 通过了以下议案： 一、 审议通过了《关于公司会计估计变更的议案》。 目前公司生产装置的质量 ...

本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示：本次会计估计变更采用未来适用法进行会计处理，不需追溯调整， 不会对辽宁奥克化学股份有限公司（以下简称"公司"）以前年度财务状况和经营 成果产生影响。本次会计估计变更预计减少2024年折旧额约5,300万元，不考虑 2024年度该类资产的增减变动，在扣除企业所得税的影响后，预计增加公司2024年 度净利润4,500万元左右，预计增加公司2024年度归属于母公司股东的净利润为 4,380万元(以上数据未经审计，最终影响金额以公司正式披露的2024年年度审计报 告为准)。 辽宁奥克化学股份有限公司 关于会计估计变更的公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-034 辽宁奥克化学股份有限公司 关于会计估计变更的公告 公司于2024年6月26日召开第六届董事会第十次会议、第六届监事会第八次会 议，审议通过了《关于公司会计估计变更的议案》。根据《深圳证券交易所创业板 股票上市规则》、《上市公司自律监管指引第2号——创业板上市公司规范运作》 等有关规定，本次会计估计变更事项无需提交股东大会审议。 ...

辽宁奥克化学股份有限公司 第六届董事会第十次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 辽宁奥克化学股份有限公司 第六届董事会第十次会议决议公告 证券代码：300082 证券简称：奥克股份 公告编号：2024-035 公司根据证监会最新监管政策要求修订《董事、监事和高级管理人员所持本 公司股份及其变动管理规则》，进一步强化对公司董事、监事和高级管理人员持 股变动管理，修订后的制度见公司同日披露的《董事、监事和高级管理人员所持 本公司股份及其变动管理规则（2024年6月修订）》。 表决结果：同意9票，反对0票，弃权0票。 1 辽宁奥克化学股份有限公司 第六届董事会第十次会议决议公告 三、备查文件 辽宁奥克化学股份有限公司（以下简称"公司"）第六届董事会第十次会议 通知于2024年6月22日以通讯、电子邮件发出，会议于2024年6月26日以通讯表决 的方式召开。本次会议应参加表决董事9名，实际参加表决董事9名。会议的召集、 召开和表决程序符合法律、法规及《公司章程》的规定。本次会议经表决，审议 通过以下议案： 一、 审议通过了《关于公司会计估计变更的议 ...

辽宁奥克化学股份有限公司 董事、监事和高级管理人员所持本公司股份及其变动管理规则 （2024 年 6 月修订） 第一条 为加强对公司董事、监事和高级管理人员所持本公司股份及其变动的 管理，进一步明确办理程序，根据《公司法》、《证券法》、《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作（2023 年 12 月修订）》及其他 相关法律法规、部门规章等，特制定本管理规则。 第二条 公司董事、监事和高级管理人员在买卖本公司股票及其衍生品种前， 应知悉《公司法》、《证券法》等法律、法规关于内幕交易、操纵市场等禁止行为的 规定，不得进行违法违规的交易。 第三条 公司董事、监事和高级管理人员在买卖本公司股票及其衍生品种前， 应当将其买卖计划以书面方式通知董事会秘书，董事会秘书应当核查公司信息披露 及重大事项等进展情况，如该买卖行为可能存在不当情形，董事会秘书应当及时书 面通知拟进行买卖的董事、监事和高级管理人员，并提示相关风险。 第四条 因公司公开或非公开发行股份、实施股权激励计划等情形，对董事、 监事和高级管理人员转让其所持本公司股份做出附加转让价格、附加业绩考核条件、 设定限售期等限制性条件的 ...

表决结果：同意 3 票，反对 0 票，弃权 0 票。 （以下无正文） 辽宁奥克化学股份有限公司 第六届董事会独立董事专门会议 辽宁奥克化学股份有限公司 第六届董事会独立董事专门会议 辽宁奥克化学股份有限公司独立董事专门会议 2024年第二次会议决议 根据中国证券监督管理委员会（以下简称"中国证监会"）《上市公司独立 董事规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公 司规范运作（2023 年 12 月修订）》、《公司章程》及《独立董事工作细则》等相 关规定的要求，辽宁奥克化学股份有限公司（以下简称"公司"）第六届董事会 独立董事专门会议 2024 年第二次会议于 2024 年 6 月 26 日以通讯表决方式召开， 会议通知已于 2024 年 6 月 22 日以电子邮件、电话等方式送达各位独立董事。 本次会议应参加表决独立董事 3 人，实际参加表决独立董事 3 人。会议的召集、 召开和表决程序符合法律、法规及《公司章程》的规定。与会独立董事审议通 过了以下议案： 一、 审议通过了《关于公司会计估计变更的议案》 经核查，我们认为：公司本次调整部分固定资产折旧年限是基于公司资产 实际情况进行 ...